1. Home
  2. DSS vs APVO Comparison

DSS vs APVO Comparison

Compare DSS & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • APVO
  • Stock Information
  • Founded
  • DSS 1984
  • APVO 2016
  • Country
  • DSS United States
  • APVO United States
  • Employees
  • DSS N/A
  • APVO N/A
  • Industry
  • DSS Containers/Packaging
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSS Consumer Discretionary
  • APVO Health Care
  • Exchange
  • DSS Nasdaq
  • APVO Nasdaq
  • Market Cap
  • DSS 7.3M
  • APVO 6.5M
  • IPO Year
  • DSS N/A
  • APVO N/A
  • Fundamental
  • Price
  • DSS $0.91
  • APVO $4.16
  • Analyst Decision
  • DSS
  • APVO Strong Buy
  • Analyst Count
  • DSS 0
  • APVO 1
  • Target Price
  • DSS N/A
  • APVO $296.00
  • AVG Volume (30 Days)
  • DSS 20.2K
  • APVO 52.2K
  • Earning Date
  • DSS 03-26-2025
  • APVO 03-04-2025
  • Dividend Yield
  • DSS N/A
  • APVO N/A
  • EPS Growth
  • DSS N/A
  • APVO N/A
  • EPS
  • DSS N/A
  • APVO N/A
  • Revenue
  • DSS $25,019,000.00
  • APVO N/A
  • Revenue This Year
  • DSS N/A
  • APVO N/A
  • Revenue Next Year
  • DSS N/A
  • APVO N/A
  • P/E Ratio
  • DSS N/A
  • APVO N/A
  • Revenue Growth
  • DSS N/A
  • APVO N/A
  • 52 Week Low
  • DSS $0.77
  • APVO $3.65
  • 52 Week High
  • DSS $2.30
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • DSS 51.10
  • APVO 37.34
  • Support Level
  • DSS $0.77
  • APVO $3.77
  • Resistance Level
  • DSS $0.99
  • APVO $4.47
  • Average True Range (ATR)
  • DSS 0.08
  • APVO 0.30
  • MACD
  • DSS 0.01
  • APVO 0.07
  • Stochastic Oscillator
  • DSS 59.09
  • APVO 31.64

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: